295. SAFETY OF SURVEILLANCE GASTROSCOPY AND ENDOSCOPIC ULTRASONOGRAPHY IN THE OESOPHAGUS AFTER NEOADJUVANT CHEMORADIOTHERAPY: RESULTS FROM THE SANO COHORT
S Panday(Erasmus MC), Sjoerd M. Lagarde(University of Amsterdam), Wouter L. Curvers(Amsterdam UMC Location University of Amsterdam), BasPL Wijnhoven(Erasmus MC Cancer Institute), Pieter C. van der Sluis(University Medical Center Utrecht), Bianca Mostert(Erasmus MC), Liekele E. Oostenbrug(Zuyderland Medisch Centrum), Manon C.W. Spaander(Erasmus University Rotterdam), Eva Kouw(Gelre Hospitals), Judith Honing(Erasmus MC), Tanya M. Bisseling(Radboud University Nijmegen), Jolein van der Kraan(Leiden University Medical Center), Rutger Quispel(Reinier de Graaf Hospital), A. Van der Linden(Ziekenhuis Groep Twente), Sietske Corporaal(Medisch Centrum Leeuwarden), Low Kuan Yean(Erasmus MC), Joost J. Nuyttens(Erasmus MC Cancer Institute), Jan JB van Lanschot(Erasmus MC Cancer Institute), Jolanda van Dieren(The Netherlands Cancer Institute), Wouter L. Hazen(Elisabeth-TweeSteden Ziekenhuis), Lieke Hol(Maasstad Ziekenhuis)
Cited by 0
Related Papers
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
|Annals of Surgery|2007|709
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
Hereditary diffuse gastric cancer: updated clinical practice guidelines
|The Lancet Oncology|2020|493